Golub Capital BDC, Inc. — Form 10-Q Summary
Reporting period: Fiscal first quarter of 2023, the three months ended December 31, 2022, with balance-sheet comparisons to September 30, 2022 and operating comparisons to the three months ended December 31, 2021. The request metadata labels this “2022 Q1,” but the filing itself reports the December 2022 quarter.
Business context and financial results
Golub Capital BDC is an externally managed business development company investing mainly in one-stop and other senior secured loans to U.S. middle-market companies. At quarter-end, investments at fair value were $5.452 billion across 332 portfolio companies; one-stop loans represented 85.4% of investments.
| Metric | Quarter ended Dec. 31, 2022 | Prior-year quarter |
|---|---|---|
| Total investment income | $136.9 million | $86.6 million |
| Total expenses | $73.0 million | $41.8 million |
| Net investment income after tax | $61.7 million; $0.36 per share | $44.8 million; $0.27 per share |
| Net increase in net assets from operations | $25.6 million; $0.15 per share | $63.1 million; $0.37 per share |
| Declared distribution per share | $0.33 | $0.30 |
Investment income rose mainly on higher floating-rate interest income, a larger average earning-loan balance and non-cash dividends. GAAP results were reduced by $39.6 million of net unrealized depreciation, compared with $4.2 million of net unrealized appreciation a year earlier. The reported net investment income after tax was about 45% of investment income; the filing does not present this as a formal margin measure.
Balance sheet, cash flow and portfolio
- Investments at fair value were $5.452 billion, slightly above $5.446 billion at September 30. Net assets were $2.514 billion, and NAV was $14.71 per share, down from $14.89.
- Debt was $3.100 billion gross ($3.084 billion net of unamortized issuance costs), versus $3.094 billion gross at September 30. Asset coverage was 180.4%; debt-to-equity was 1.24x. The company reported a $1.238 billion JPM facility, with $538.9 million of remaining availability subject to borrowing-base and leverage limits.
- Cash and cash equivalents were $96.4 million; restricted cash was $62.8 million. Operating activities provided $52.9 million, while financing activities used $67.5 million. Cash, foreign currencies and restricted cash together decreased $14.6 million during the quarter.
- Portfolio fair value was concentrated in software (26.5%) and healthcare providers and services (8.2%). Non-accrual loans rose to $92.2 million fair value, or 1.8% of debt investments at fair value, from $65.1 million and 1.3%; they involved nine companies versus eight.
- Quarter-end fair value of investments exceeded amortized cost by $131.5 million. Nearly all portfolio investments were valued using Level 3 inputs, which rely on significant unobservable assumptions.
Material changes, outlook and risks
- Compared with the prior-year quarter, investment income increased $50.3 million, but expenses rose $31.2 million, including higher financing costs and incentive fees. Net income from operations fell $37.5 million, primarily reflecting the swing to unrealized depreciation.
- Management attributed the quarter’s unrealized depreciation mainly to market spread widening, with a smaller contribution from deterioration at a limited number of portfolio companies. The effective annualized average cost of total debt increased to 4.4% from 2.7% a year earlier.
- Floating-rate exposure benefits income when rates rise but also raises borrowing costs. The filing estimates that an immediate 100-basis-point rate increase would increase annualized investment income by $53.3 million and interest expense by $16.1 million, for a $37.2 million increase in net investment income, holding other factors constant. A 100-basis-point decline would reduce it by the same estimated amount.
- As of December 31, unfunded investment commitments totaled $200.2 million, including $32.3 million on undrawn revolvers. Management said liquidity was sufficient for these obligations, citing cash, facility availability and investment repayments.
- The Board declared a $0.33-per-share distribution payable March 29, 2023. The filing provides no earnings or distribution guidance. Other disclosed risks include portfolio credit and valuation uncertainty, leverage and funding access, foreign-currency exposure, and the transition of securitizations from LIBOR; management said it may amend or refinance those securitizations before three-month USD LIBOR ends June 30, 2023.
Management reported effective disclosure controls and no material change in internal control over financial reporting. It reported no material change to the risk factors in the prior Form 10-K and no legal proceedings believed likely to materially affect the financial statements.
Important facts for investors to verify
- Whether the rise in non-accrual investments and quarter-end Level 3 marks persist, especially under continued spread widening or weaker borrower performance.
- How much of reported investment income and distributions is supported by cash receipts versus PIK interest or non-cash dividends; the quarter included $7.8 million of PIK interest and $3.4 million of non-cash dividends.
- The impact of higher financing costs, the $501.8 million of 2024 Notes due within one to three years, and refinancing or benchmark-transition terms for the LIBOR-linked securitizations.
- That the declared $0.33 distribution is sustainable relative to recurring net investment income, taxes and portfolio credit conditions.